Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women
- Conditions
- Melasma
- Interventions
- Drug: 20-30% Salicylic Acid peels to the right side of the faceDrug: 20-30% Salicylic Acid peels to the left side of the face
- Registration Number
- NCT00616239
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Brief Summary
This study will enroll 20 adult Hispanic women. Participants will apply 4% hydroquinone cream twice daily to affected areas on the face for 14 weeks and half the face will be peeled with 20-30% salicylic acid every two weeks for a total of 4 peels. The first two peels will be 20% salicylic acid and the second two peels will be with 30% salicylic acid. The purpose of the study will be to evaluate the safety and efficacy of salicylic acid combined with 4% hydroquinone versus 4% hydroquinone alone.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 20
- Hispanic women ages 18-65 years of age with moderate to severe melasma
- English and Spanish-speaking women
- Pregnant or breast-feeding women
- Subjects who have used 4% hydroquinone within 3 months of study start
- Subjects who have used chemical peels, microdermabrasion or facial laser treatments within 9 months of study start
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description A 20-30% Salicylic Acid peels to the right side of the face Subjects randomized to have the right side of the face peeled with salicylic acid every 2 weeks for a total of 4 peels (first 2 at 20% and last 2 at 30%). Subjects will apply 4% hydroquinone cream to affected areas on entire face for 14 weeks. B 20-30% Salicylic Acid peels to the left side of the face Subjects randomized to have the left side of the face peeled with salicylic acid every 2 weeks for a total of 4 peels (first 2 at 20% and last 2 at 30%). Subjects will apply 4% hydroquinone cream to affected areas on entire face for 14 weeks.
- Primary Outcome Measures
Name Time Method Number of Participants Showing Improvement of Melasma Based on Mexameter Readings 14 weeks Improvement of melasma on the peel side using mexameter reading
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials
🇺🇸Dallas, Texas, United States